OneDraw A1C Test System
Assay, Glycosylated Hemoglobin. 510(k) K183230, from Drawbridge Health, Inc. (San Diego, CA). Product code LCP, class 2.
As of Nov 20, 2026, K183230 is an FDA 510(k) held by Drawbridge Health, Inc., substantially equivalent on Aug 15, 2019 after 268 days, with no recalls tied to it in FDA's recall database.
- Review time: 268 days
- Recalls: 0
The OneDrawâ„¢ A1C Test System, which consists of the OneDraw Blood Collection Device and the OneDraw A1C Test, is intended to collect capillary blood from the upper arm of individuals 18 years of age or older onto filter (matrix) paper within the collection device by a healthcare professional.
- Home Access Aic TestK141944 · Home Access Health Corp. · Mar 13, 2015
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 20, 2018
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files